CardioExchange Archive

October 1st, 2014

Case: Testosterone Replacement Therapy and CV Risk

Seth D Bilazarian, MD, Anna Catino, MD and James Fang, MD

A 47-year-old man presents to the hospital reporting 4 days of chest pain that occurs during treadmill exercise, left-arm and jaw discomfort, and shortness of breath with diaphoresis. His medical history is noteworthy only for orthopedic surgeries and use of testosterone replacement therapy for reportedly low testosterone syndrome. He does not smoke and drinks alcohol only occasionally. He […]

---

June 23rd, 2014

FDA: Risk for Venous Thromboembolism with All Testosterone Products

Kristin J. Kelley, CardioExchange Staff

The FDA is requiring an expanded label change to all approved testosterone products to warn of the increased risk for venous thromboembolism. Labels currently address the risk for clots associated with polycythemia caused by testosterone treatment. The action follows reports of blood clots in testosterone users unrelated to polycythemia. The agency says the warning is not […]

---

February 3rd, 2014

FDA Evaluating Safety Of Testosterone Products

Larry Husten, PHD

The FDA has announced that it is evaluating the cardiovascular safety of testosterone products. The investigation is prompted by two recent published studies that found a significant increase in cardiovascular events in men who received testosterone therapy. The FDA said it had not concluded that testosterone is unsafe but recommended that “health care professionals should consider […]

---

November 11th, 2013

Selections from Richard Lehman’s Literature Review: November 11th

Richard Lehman, BM, BCh, MRCGP

This week’s topic is the association between testosterone therapy with mortality, MI, and stroke in men with low testosterone.

---

November 5th, 2013

Should You Be Worried About the Treatment for Low-T?

Larry Husten, PHD

The ubiquitous ads ask: “Should I be worried about Low-T”? But now there’s a good chance there’s a more important question: “Should I be worried about the treatment for low-T?” A new study published in JAMA raises the distinct possibility that testosterone therapy may increase the risk for death, heart attack, and stroke. The findings are hardly definitive, but they may […]

---